Kathryn A. Romano

2021

In 2021, Kathryn A. Romano earned a total compensation of $3.5M as Chief Accounting Officer at Krystal Biotech, a 76% increase compared to previous year.

Compensation breakdown

Bonus$157,500
Option Awards$1,500,427
Salary$283,333
Stock Awards$1,546,242
Other$11,600
Total$3,499,103

Romano received $1.5M in stock awards, accounting for 44% of the total pay in 2021.

Romano also received $157.5K in bonus, $1.5M in option awards, $283.3K in salary and $11.6K in other compensation.

Rankings

In 2021, Kathryn A. Romano's compensation ranked 3,829th out of 12,397 executives tracked by ExecPay. In other words, Romano earned more than 69.1% of executives.

ClassificationRankingPercentile
All
3,829
out of 12,397
69th
Division
Manufacturing
1,568
out of 5,492
71st
Major group
Chemicals And Allied Products
640
out of 2,367
73rd
Industry group
Drugs
569
out of 2,090
73rd
Industry
Biological Products, Except Diagnostic Substances
151
out of 452
67th
Source: SEC filing on April 7, 2022.

Romano's colleagues

We found three more compensation records of executives who worked with Kathryn A. Romano at Krystal Biotech in 2021.

2021

Andrew Orth

Krystal Biotech

Chief Commercial Officer

2021

Krish Krishnan

Krystal Biotech

Chief Executive Officer

2021

Suma Krishnan

Krystal Biotech

President, R&D

News

You may also like